期刊文献+

生长激素缺乏症儿童血清瘦素、骨钙素水平变化及其相关性分析 被引量:3

Changes of Serum Leptin and Osteocalcin in Children with Growth Hormone Deficiency and Correlation between Leptin and Osteocalcin
下载PDF
导出
摘要 目的观察生长激素缺乏症(GHD)儿童血清瘦素(LEP)、骨钙素(OC)水平的变化及两者相关性分析。方法分别测定32例GHD儿童重组人生长激素(rhGH)替代治疗前、治疗后3个月和35例性别、年龄匹配的正常健康儿童的血清LEP、OC,比较各组差异,并对LEP和OC进行相关性分析。结果GHD治疗前组血清LEP水平显著高于正常对照组(P<0.05),rhGH治疗3个月后LEP较基线值显著性降低。而GHD治疗前组血清OC水平显著低于正常对照组(P<0.05),rhGH治疗3个月后OC较基线值显著性增高,血清LEP、OC无显著相关性(r=0.281,P>0.05)。结论GHD儿童LEP水平的改变依赖于GH引起的体脂量的变化;GHD儿童骨代谢的调控很可能与LEP无关。 Objective To study changes of serum leptin and osteocalcin in children with growth hormone deficiency(GHD) and correlation beteen leptin and osteocalcin. Methods To measure serum leptin and osteocalcin respectively in 32 GHD children (before and after 3 months of recombinant human growth hormone therapy)and 35 sex- and agematched healthy controls. To analyse correlation beteen leptin and osteocalcin. Results Compared with the control,the serum levels of leptin in pre-treatment GHD group were significantly increased (P〈0.05). Compared with the pre-treatment GHD group ,the serum levels of leptin in 3-inonth-treatment GHD group were significantly decreased (P〈0.05). While,Compared with the control,the serum levels of osteocalcin in pre-treatment GHD group were significantly decreased (P〈0.05). Compared with the pre-treatment GHD group, the serum levels of osteocalcin in 3-month-treatment GHD group were significantly increased(P〈0.05). There was no significant con'elation between leptin and osteocaicin(r = 0.281,P〉0.05). Conclusion Changes of serum leptin in GHD children was depended on the change of body fat mass which was brought by GH. The adjustment and control of bone metabolism in GHD children might have no relationship with leptin.
出处 《中国现代医生》 2008年第24期9-10,共2页 China Modern Doctor
关键词 生长激素缺乏症 瘦素 骨钙素 相关性 Growth hormone deficiency Leptin Osteocalcin Correlation
  • 相关文献

参考文献4

二级参考文献50

  • 1陈翠珠,曲强.瘦素在骨髓基质干细胞向成骨细胞分化早期的作用研究[J].中国骨质疏松杂志,2004,10(2):158-161. 被引量:7
  • 2傅春江,王旭开,杨成明,王红勇,方玉强,石伟彬.重组生长激素对兔血脂及肝脏LDL受体mRNA的影响[J].第三军医大学学报,2005,27(8):753-755. 被引量:9
  • 3赵正言,傅君芬.小儿内分泌疾病的诊治:儿科医师的新挑战[J].浙江大学学报(医学版),2005,34(4):287-292. 被引量:2
  • 4胡亚美 江载芳.诸福棠实用儿科学[M](第7版)[M].北京:人民卫生出版社,2002.1199-1201.
  • 5Froguel P, Guy-Grand B, Clement K. Genetics of obesity: towards the understanding of a complex syndrome. Presse Med,2000,29:564-571.
  • 6Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell,2000,100: 197-207.
  • 7Odabasi E, Ozata M, Turan M, et al. Plasma leptin concentrations in postmenopausal women with osteoporosis. Eur J Endocrinol, 2000, 142:170-173.
  • 8Ebihara K, Ogawa Y, Masuzaki H, et al. Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. Diabetes, 2001,50:1440-1448.
  • 9Burguera B, Hofbauer LC, Thomas T, et al. Leptin reduces ovariectomyinduced bone loss in rats. Endocrinology, 2001,142: 3546-3553.
  • 10Cornish J, Callon KE, Bava U, et al. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. J Endocrinol, 2002,175:405-415.

共引文献10

同被引文献35

  • 1傅春江,王旭开,杨成明,王红勇,方玉强,石伟彬.重组生长激素对兔血脂及肝脏LDL受体mRNA的影响[J].第三军医大学学报,2005,27(8):753-755. 被引量:9
  • 2林君红,梁黎,邹朝春,王春林,蒋优君,董关萍.重组人生长激素对生长激素缺乏儿童脂代谢和脂联素水平的影响[J].实用儿科临床杂志,2006,21(20):1377-1378. 被引量:5
  • 3Moiler N,Jorgensen JO.Effects of growth hormone on glucose,lipid,and protein metabolism in human subjects[J].Endocr Rev,2009,30(2):152-177.
  • 4Lanes R,Paoli M,Carrillo E,et al.Peripheral inflammatory and fibrinolytic markers in adolescents with growth hormone deficiency:Relation to postprondial dyslipidemia[J].J Pediatr, 2004,145(5) :657-661.
  • 5Gleson HK,Souza AH,Gill MS,et al.Lipid profiles in untreated severe congenital isolated growth hormone deficiency through the lifespan [J].Clin Endocfinol (Oxf), 2002,57 ( 1 ): 89-95.
  • 6Esposito V,Biase SDI,Lettiero T,et al.Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement[J].Clin Endocrinol, 2004,61 (5) :607-611.
  • 7Kim DS,Itoh E,Iida K,et al.Growth hormone increases mRNA levels of PPARdeha and Foxol in skeletal muscle of growth hormone deficient lit/lit mice [J].Endocr J,2009,56 ( 1 ):141-147.
  • 8Allemand D,Eiholzer U,Sehlumpf M,et al.Cardiovascular risk factors improve during 3 years of growth hormone therapy in Prader-Willi syndrome [J].Eur J Pediatr,2000,159 ( 11 ):835-842.
  • 9Misra M,Bredella MA,Tsai P,et al.Lower growth hormone and higher cortisol are associated with greater visceral adiposity,intramyocellular lipids,and insulin resistance in overweight girls [J].Am J Physiol Endocrinol Metab,2008,295 (2) :385-392.
  • 10Lanes R,Soros A, Flores K,et al.Endothelial function, carotid artery intima -media thickness,epicardial adipose tissue,and left ventricular mass and function in growth hormone-deficient adolescents:Apparent effects of growth hormone treatment on these parameters [J].J Clin Endocrinol Metab, 2005,90(7) :3978-3982.

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部